The single dose pharmacokinetics of ribavirin in subjects with chronic liver disease - Wikidata - awgldk - TriplyDB

The single dose pharmacokinetics of ribavirin in subjects with chronic liver disease

The single dose pharmacokinetics of ribavirin in subjects with chronic liver disease

http://www.wikidata.org/entity/Q36055167

about

Pharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal Impairment Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy Ribavirin in the treatment of chronic hepatitis C.Viral hepatitis C therapy: pharmacokinetic and pharmacodynamic considerations.Variations of pharmacokinetics of drugs in patients with cirrhosis.Feasibility of ribavirin therapeutic drug monitoring in hepatitis C.Ribavirin in chronic hepatitis C: past and future.Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection.Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals.Pharmacokinetics, safety, and tolerability of ribavirin in hemodialysis-dependent patients.Ribavirin exposure after the first dose is predictive of sustained virological response in chronic hepatitis C.

P2860

Q26751452-21BC3185-8B99-4A83-BEF5-69E00F9D7E0E Q36180241-C774CCAA-9C7C-4D2F-8EA7-E81DEDEB30B3 Q37195248-55ED69B8-B1C3-4BD1-A905-243945F60963 Q38203823-5BB3EB13-25DE-45F6-A786-44111ACED59C Q38676890-CC3CE81B-1237-4073-BE78-A7709212C0C3 Q41144825-B7B8A3C2-9B20-45C3-A865-0CB646E80BAD Q42986680-F7E5A20F-62D3-4916-B695-81EEB0DF4677 Q44211421-E3115E77-CCCB-4570-8774-153930FE7A0F Q47141239-346411AE-1401-46FB-B9F0-5E1017279A80 Q50554702-92271AA0-67B8-4EC0-9C1C-BEE3C198AB7B Q50568686-2EF08461-B858-4769-A4BC-78D1E1F0CCA0

P2860

The single dose pharmacokinetics of ribavirin in subjects with chronic liver disease

http://www.wikidata.org/entity/Q36055167

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

2000年论文

@zh

2000年论文

@zh-cn

name

The single dose pharmacokinetics of ribavirin in subjects with chronic liver disease

@ast

The single dose pharmacokinetics of ribavirin in subjects with chronic liver disease

@en

type

label

The single dose pharmacokinetics of ribavirin in subjects with chronic liver disease

@ast

The single dose pharmacokinetics of ribavirin in subjects with chronic liver disease

@en

prefLabel

The single dose pharmacokinetics of ribavirin in subjects with chronic liver disease

@ast

The single dose pharmacokinetics of ribavirin in subjects with chronic liver disease

@en

P1433

Q36055167-142F9839-A7A0-4A6A-A851-B4FEAABE4E19

P1476

Q36055167-6E77B607-8BDB-416C-BC2B-5A4C1D7BD598

P2093

Q36055167-2B20D24C-AE80-4772-9AFD-9FEDEC3EA7A9

Q36055167-35524BCF-81CE-4432-BF2D-3EF27E5C4136

Q36055167-60A810F3-B8B3-41A9-B467-22C8C696A4F1

Q36055167-92A215DE-246A-4484-A428-7911B5908714

Q36055167-EAACE3EA-9BAC-4DDA-8487-EF544703CBE0

P2860

Q36055167-08508892-725D-455C-A0D2-EBCDFBB4EDFC

Q36055167-099E4587-32EF-4573-B6C3-1711BA221753

Q36055167-16994AE6-5FB2-4493-B008-22D3153714FE

Q36055167-214D05B0-7A92-405D-942F-2A95602A3693

Q36055167-32EE3204-7A9B-4304-B0C0-9C2F55955261

Q36055167-48D0697C-2865-4839-87AC-0090752845A4

Q36055167-8D86ABBA-7DD9-4999-8D10-D47E06AA87E5

Q36055167-93F8CA3D-7D6F-4304-98C4-B4D6BA7B74B9

Q36055167-A2068CBC-FB75-405F-9A75-670BA15686D9

Q36055167-AC99EE6B-1696-4C53-BD3D-8FB4C15C20AC

P304

Q36055167-90C3032B-7224-4DA7-9184-AFB3E3E10FE1

P31

Q36055167-F995CD84-0EA8-4AA9-A840-36D9EF623E4E

P356

Q36055167-39138EFE-F92B-479D-94F9-5E210CDB5473

P407

Q36055167-5CFE74B2-8A38-409E-9DD0-31A424336359

P433

Q36055167-B50D0708-B38C-44E1-BA86-CC61D09641F2

P478

Q36055167-BAFC7CCF-D04A-452F-96DC-432B077708EC

P50

Q36055167-899B8528-F8E3-43A8-8CC8-221DB7172B5A

P577

Q36055167-CBEFB93C-E86C-4F27-91D5-D2AB32115B10

P5875

Q36055167-22D95D7F-42F5-4E0E-9FF4-1CBA25F6A657

P698

Q36055167-32533DA9-ECD7-43F8-9A1F-EEF8804E2265

P932

Q36055167-A84AA5DA-6BF6-4979-869D-7D60AFA05777

P356

J.1365-2125.2000.00186.X

P1433

British Journal of Clinical Pharmacology

P1476

The single dose pharmacokinetics of ribavirin in subjects with chronic liver disease

@en

P2093

D Zambas

http://www.w3.org/2001/XMLSchema#string

M Salfi

http://www.w3.org/2001/XMLSchema#string

R P Clement

http://www.w3.org/2001/XMLSchema#string

S Gupta

http://www.w3.org/2001/XMLSchema#string

S Schenker

http://www.w3.org/2001/XMLSchema#string

P2860

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide

Ribavirin: an antiviral agent

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

The clinical pharmacology of ribavirin.

Transection of the oesophagus for bleeding oesophageal varices.

Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions.

Clinical pharmacokinetics in patients with liver disease.

Pharmacokinetics and absolute bioavailability of ribavirin in healthy volunteers as determined by stable-isotope methodology.

Ribavirin: a clinical overview.

P304

417-421

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2125.2000.00186.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P50

P577

2000-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12525570

http://www.w3.org/2001/XMLSchema#string

P698

10792198

http://www.w3.org/2001/XMLSchema#string

P932

2014952

http://www.w3.org/2001/XMLSchema#string